Back to Search
Start Over
Effects of catecholamines on thymocyte apoptosis and proliferation depend on thymocyte microenvironment
- Source :
- Journal of Neuroimmunology
- Publication Year :
- 2014
- Publisher :
- Elsevier Science BV, Amsterdam, 2014.
-
Abstract
- The present study, through quantification of tyrosine hydroxylase (TH) expression and catecholamine (CA) content in the presence and in the absence of alpha-methyl-p-tyrosine (AMPT), a TH inhibitor, in adult thymic organ (ATOC) and thymocyte culture, demonstrated that thymic cells produce CAs. In addition, in ATOC an increase in beta(2)-adrenoceptor (AR) mRNA expression and beta(2)-AR thymocyte surface density was registered. Furthermore, AMPT (10(-4) M), as propranolol (10(-4) M), augmented thymocyte apoptosis and diminished thymocyte proliferation in ATOC. Propranolol exerted these effects acting on CD3(high) thymocytes. However, in thymocyte cultures, propranolol (10(-6) M) acting on the same-thymocyte subset exerted the opposing effect on thymocyte apoptosis and ConA-stimulated proliferation. This suggested that, depending on thymocyte microenvironment, differential effects can be induced through the same type of AR. Additionally, arterenol (10(-8) to 10(-6) M), similar to propranolol, diminished apoptosis, but increased ConA-stimulated thymocyte proliferation in thymocyte culture. However, differently from propranolol, arterenol affected manly CD3- thymocyte subset, which harbors majority of alpha(1)-AR+ thymocytes. Additionally, arterenol showed a dose-dependent decrease in efficiency of thymocyte apoptosis and proliferation modulation with the rise in its concentration. Considering greater affinity of arterenol for alpha(1)-ARs than for beta(2)-ARs, the previous findings could be attributable to increased engagement of beta(2)-ARs with the rise of arterenol concentration. Consistently, in the presence of propranolol (10(-6) M), a beta-AR blacker, the arterenol (10(-8) M) effects on thymocytes were augmented. In conclusion, thymic endogenous CAs, acting through distinct AR types and, possible, the same AR type (but in different cell microenvironment) may exert the opposing effects on thymocyte apoptosis/proliferation. (C) 2014 Elsevier B.V. All rights reserved.
- Subjects :
- medicine.medical_specialty
Tyrosine 3-Monooxygenase
CD3
Immunology
Adrenergic beta-Antagonists
Endogeny
Apoptosis
Propranolol
Thymus Gland
Biology
Lymphocyte Activation
AMPT
Norepinephrine
Catecholamines
Organ Culture Techniques
Internal medicine
medicine
Immunology and Allergy
Animals
Enzyme Inhibitors
Cells, Cultured
Cell Proliferation
Thymocyte culture
Thymocytes
Thymocyte proliferation
Tyrosine hydroxylase
Cell Differentiation
Adult thymus organ culture
Rats
Thymocyte
Endocrinology
alpha-Methyltyrosine
Neurology
Arterenol
Catecholamine
biology.protein
Neurology (clinical)
Adrenergic alpha-Agonists
Thymocyte apoptosis
medicine.drug
Subjects
Details
- Database :
- OpenAIRE
- Journal :
- Journal of Neuroimmunology
- Accession number :
- edsair.doi.dedup.....d5442c3d1c2e4fff9a2e5b8171814b2c